Showing results (981-990 of 1,007) with videos related to

Sort By:
Pageof 101
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast CancerIan Krop, Vandana Abramson, Marco Colleoni, et al.
Cell Reports. Medicine|March 18, 2026
Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humansHenning Tim Langer, Natalie K Gilmore, Christopher M T Hayden, et al.
Blood|June 2, 2021
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemiaHassan Awada, Arda Durmaz, Carmelo Gurnari, et al.
Nature Communications|November 28, 2019
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromesYasunobu Nagata, Hideki Makishima, Cassandra M Kerr, et al.
Blood Advances|November 12, 2021
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromesCarmelo Gurnari, Simona Pagliuca, Yihong Guan, et al.
Scientific Reports|December 21, 2022
The field of human building interaction for convergent research and innovation for intelligent built environmentsBurcin Becerik-Gerber, Gale Lucas, Ashrant Aryal, et al.
The Lancet. Oncology|June 4, 2017
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trialJosé Baselga, Seock-Ah Im, Hiroji Iwata, et al.
Breast Cancer Research and Treatment|June 27, 2007
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative studyPatrick Neven, Robert Paridaens, Gino Pelgrims, et al.
Blood Advances|November 13, 2024
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter studyBruno Fattizzo, Alfredo Marchetti, Alessandro Bosi, et al.
ESMO Open|August 28, 2020
Oncological care organisation during COVID-19 outbreakConcetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
Pageof 101